Unlike other types of breast cancer, neither hormonal therapy such as tamoxifen or aromatase inhibitors, nor targeted therapy against HER2 using Herceptin (Trastuzumab), are effective against these neoplastic cells. Here, ERBB2 is linked to breast cancer.